Latest news articles

Added 11 months ago Drug news

Urovant Sciences licenses vibegron from Merck Inc. and will initiate a Phase III trial in 2017 for overactive bladder treatment.

Roivant Sciences, announced the formation of Urovant Sciences, a new company focused on developing innovative therapies for urologic conditions. Urovant's...

Added 2 years ago Drug news

Phase III extension studies show advantages of Botox (onabotulinumtoxinA) in urinary incontinence- Allergan

Allergan has announced that results from an extension study of two phase III trials showed that long-term Botox (onabotulinumtoxinA) treatment...

Search all news articles for Other diseases of bladder and urethra
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Transplantation

Transplantation

See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Fabry Disease

Fabry Disease

Explore the pathophysiology and treatment options for Fabry disease, a deficiency of the lysosomal enzyme alpha-galactosidase A

Load more

Guidelines

Guidelines on Paediatric Urology

The majority of urological clinical problems in children are specialised and in many ways differ to those in adults. This publication intends to outline a practical and preliminary approach to paediatric urological conditions.

Added 2 years ago

Guidelines on the Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS)

The present Guidelines offer practical evidence-based guidance on the assessment and treatment of men aged 40 years or older with various non-neurogenic benign forms of LUTS.

Added 2 years ago

Search all guidelines for Other diseases of bladder and urethra
 

Journal articles

Association between coronary artery disease severity and overactive bladder in geriatric patients.

Purpose: To investigate the association between overactive bladder (OAB) and coronary artery disease (CAD) as demonstrated on coronary angiography in patients > 65 years.

Added 4 months ago

Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis.

Objectives: To compare the efficacy of onabotulinumtoxinA, mirabegron, and anticholinergics in adults with idiopathic overactive bladder (OAB) using network meta-analysis (NMA).

Added 4 months ago

Enuresis and overactive bladder in children: what is the relationship between these two conditions?

Evaluate clinical aspects associated with the presence of nocturnal enuresis (NE) in children with a diagnosis of overactive bladder (OAB).

Added 1 year ago

Search all journal articles for Other diseases of bladder and urethra
 

CME

Daytime wetting in children

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
0
Registration required
0
Subscription fee
0
Search all CME for Other diseases of bladder and urethra